CCM
EVFM

Consonance Capital Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Consonance Capital Management’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,359
Closed -$987K – 29
2015
Q3 		$987K Buy
+1,359
New +$1.46M 0.14% 26

Other funds holding EVFM

CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Consonance Capital Management's EVFM Position: Q4 2015 in Review

Consonance Capital Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2015, closing a stake of 1,359 shares — an estimated $987K sold.

Consonance Capital Management first reported a position in EVFM in Q3 2015 and held it in 1 quarter. The position peaked at $987K in Q3 2015. 24 funds tracked by Wall St. Rank hold EVFM as of Q4 2015.

  • Consonance Capital Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Consonance Capital Management sold 1,359 Evofem Biosciences, Inc. Common Stock shares in Q4 2015, an estimated $987K.
  • Consonance Capital Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Consonance Capital Management's Evofem Biosciences, Inc. Common Stock position peaked at $987K in Q3 2015.
  • 24 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2015.

Based on Consonance Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.